ATE13911T1 - Verfahren zur herstellung von interferoninduzierenden immunostimulierenden proteoglykanen, die so erhaltenen proteoglykane und das dieselben enthaltende arzneimittel. - Google Patents

Verfahren zur herstellung von interferoninduzierenden immunostimulierenden proteoglykanen, die so erhaltenen proteoglykane und das dieselben enthaltende arzneimittel.

Info

Publication number
ATE13911T1
ATE13911T1 AT83400445T AT83400445T ATE13911T1 AT E13911 T1 ATE13911 T1 AT E13911T1 AT 83400445 T AT83400445 T AT 83400445T AT 83400445 T AT83400445 T AT 83400445T AT E13911 T1 ATE13911 T1 AT E13911T1
Authority
AT
Austria
Prior art keywords
proteoglycans
interferon
immunostimulating
inducing
preparation
Prior art date
Application number
AT83400445T
Other languages
English (en)
Inventor
D Hinterland Lucien Dussourd
Gerard Normier
Anne-Marie Pinel
Original Assignee
Fabre Sa Pierre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9271781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE13911(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fabre Sa Pierre filed Critical Fabre Sa Pierre
Application granted granted Critical
Publication of ATE13911T1 publication Critical patent/ATE13911T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26—Klebsiella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT83400445T 1982-03-09 1983-03-04 Verfahren zur herstellung von interferoninduzierenden immunostimulierenden proteoglykanen, die so erhaltenen proteoglykane und das dieselben enthaltende arzneimittel. ATE13911T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8203921A FR2523154A1 (fr) 1982-03-09 1982-03-09 Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
EP83400445A EP0089266B2 (de) 1982-03-09 1983-03-04 Verfahren zur Herstellung von interferoninduzierenden immunostimulierenden Proteoglykanen, die so erhaltenen Proteoglykane und das dieselben enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ATE13911T1 true ATE13911T1 (de) 1985-07-15

Family

ID=9271781

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83400445T ATE13911T1 (de) 1982-03-09 1983-03-04 Verfahren zur herstellung von interferoninduzierenden immunostimulierenden proteoglykanen, die so erhaltenen proteoglykane und das dieselben enthaltende arzneimittel.

Country Status (8)

Country Link
US (1) US4501693A (de)
EP (1) EP0089266B2 (de)
JP (1) JPS58164514A (de)
AT (1) ATE13911T1 (de)
CA (1) CA1197801A (de)
DE (1) DE3360289D1 (de)
ES (1) ES520349A0 (de)
FR (1) FR2523154A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2540136A1 (fr) * 1983-01-28 1984-08-03 Roussel Uclaf Nouveau procede de preparation d'acylglycoproteines immunostimulantes extraites de klebsiella pneumoniae, compositions pharmaceutiques et procede de lutte contre les maladies allergiques
FR2570081B1 (fr) * 1984-09-10 1987-01-09 Pf Medicament Polysaccharides membranaires utiles notamment comme medicament et procede pour leur preparation
FR2574429B1 (fr) * 1984-12-06 1987-12-11 Roussel Uclaf Acylglycannes extraits de klebsiella, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2598434B1 (fr) * 1986-05-12 1988-09-16 Pf Medicament Nouveaux immunomodulateurs obtenus par hemisynthese a partir d'un polysaccharide bacterien isole d'une souche mutante non capsulee de klebsiella pneumoniae
FR2614306B1 (fr) * 1987-04-22 1989-07-28 Pf Medicament Nouveau derive de d.25, procede de preparation, utilisation a titre d'agent immunostimulant et compositions pharmaceutiques le contenant.
FR2650506B1 (fr) * 1989-07-11 1991-11-08 Roussel Uclaf Galactanne extrait de klebsiella, procede d'obtention et application a titre de medicament
CH680192A5 (de) * 1989-12-13 1992-07-15 Nestle Sa
DE4308443C2 (de) * 1993-03-17 1996-09-19 Laves Hans Georg Arzneimittel zur Behandlung von Retrovirusinfektionen
FR2790960B1 (fr) * 1999-03-15 2002-10-31 Pf Medicament Utilisation de fractions membranaires bacteriennes a activite immunostimulante dans le traitement de cancers, leurs procedes de preparation et les compositions pharmaceutiques les contenant
GB0006333D0 (en) 2000-03-16 2000-05-03 Raychem Ltd Electrical wire insulation
JP2022520999A (ja) * 2019-02-22 2022-04-04 エヴェロ バイオサイエンシズ，インコーポレーテッド 細菌の膜調製物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855197A (en) * 1969-05-20 1974-12-17 Cassenne Lab Sa Glycoproteins extracted from microorganisms
FR2088112B2 (de) * 1970-05-20 1975-01-10 Cassenne Lab Sa
FR2160326B1 (de) * 1971-11-19 1975-02-07 Anvar
BE795417A (fr) * 1972-02-15 1973-08-14 Roussel Uclaf Nouveaux composes d'origine-bacterienne et procede d'obtention
US3976544A (en) * 1973-06-19 1976-08-24 The Agence Nationale De Valorisation De Le Recherche Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
FR2248025A2 (en) * 1973-10-23 1975-05-16 Anvar Vaccine compsns. - contg. N-acyl muramic acid deriv. as adjuvant
FR2315945A1 (fr) * 1975-07-03 1977-01-28 Cassenne Lab Sa Nouvelles glycoproteines isolees d'aerobacter cloacae, procede de preparation et application a titre de medicaments de ces produits
FR2405298A1 (fr) * 1977-01-27 1979-05-04 Cassenne Lab Sa Nouvelles glycoproteines isolees d'escherichia coli, procede de preparation et application de medicaments
FR2378855A1 (fr) * 1977-01-27 1978-08-25 Cassenne Lab Sa Nouvelles glycoproteines isolees d'hafnia, procede de preparation et application a titre de medicaments
FR2444464A1 (fr) * 1978-12-19 1980-07-18 Fabre Sa Pierre Proteoglycanes bacteriens purifies, procede pour leur preparation et vaccin les contenant
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2490495A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines hydrosolubles immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
US4451446A (en) * 1982-03-04 1984-05-29 Smithkline-Rit Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them

Also Published As

Publication number Publication date
ES8401135A1 (es) 1983-12-16
JPS58164514A (ja) 1983-09-29
US4501693A (en) 1985-02-26
DE3360289D1 (en) 1985-07-25
JPH0587519B2 (de) 1993-12-16
EP0089266A1 (de) 1983-09-21
EP0089266B2 (de) 1989-08-30
EP0089266B1 (de) 1985-06-19
FR2523154A1 (fr) 1983-09-16
FR2523154B1 (de) 1984-12-14
CA1197801A (fr) 1985-12-10
ES520349A0 (es) 1983-12-16

Similar Documents

Publication Publication Date Title
AU553185B2 (en) Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
ATE13911T1 (de) Verfahren zur herstellung von interferoninduzierenden immunostimulierenden proteoglykanen, die so erhaltenen proteoglykane und das dieselben enthaltende arzneimittel.
IT8349510A0 (it) Procedimento per la produzione di acido ialuronico da colture batteriche
MX9708438A (es) Proteina principal de la membrana externa de moraxella, de alto peso molecular.
DE3772221D1 (de) Suessware und verfahren zur herstellung derselben.
BE881014A (fr) Procede de preparation d'organopolysiloxanes, et produits ainsi obtenus
ES8104412A1 (es) Procedimiento para la preparacion de un hidrolizado de pro- teinas purificado.
HUT50048A (en) Process for producing streptococcus protein antigen and pharmaceutical compositions comprising same
BE837709A (fr) Procede de preparation d'antigene d'hepatite b purifiee et produits obtenus
GR3017427T3 (en) Composition and method for protecting against diseases caused by microorganisms.
JPS5782322A (en) Novel immunostimulant sugar protein extracted from pneumonia bacillus,obtaining method, application as drug and composition containing same
ES527230A0 (es) Metodo de preparar productos lacteos en polvo
AU586224B2 (en) Method of preparing perfluoropolyethers having regulared molecular weight from the product obtained by photochemical oxidation of C``F``
DE3273463D1 (en) Process for the preparation of cyclohexene derivatives, and a starting product and intermediary products in this process
FR2384779A1 (fr) Nouvelles oximes derivees de l'acide 3-chloro ou 3-methoxy 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
AT336784B (de) Verfahren zur herstellung eines atoxischen, immunogenen produktes aus tetanus-toxin
JPS5782321A (en) Novel water-soluble immunostimulant sugar protein extracted from pneumonia bacillus, obtaining method,application as drug and composition containing same
FR2381053A1 (fr) Nouvelles oximes derivees de l'acide 3-thiadiazolyl thiomethyl 7-aminothiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
ATE62248T1 (de) Ein doxorubicinderivat, ein verfahren zu dessen herstellung, pharmazeutische zusammensetzungen und dessen verwendung fuer die herstellung von arzneimitteln.
UA5567A1 (uk) Спосіб отримання d-l-амінокислот
DE3363975D1 (en) Polysaccharide substance, process for the production of same, pharmaceutical compositions containing the same and their use as medicaments
BE791871A (fr) Procede de preparation d'esters d'imido-acide cycliques, et produits obtenus
FR2418235A1 (fr) Procede de preparation d'acides 7-imidazolidinyl substitue 3-chloro-3-cephem-4-carboxyliques et nouveaux produits ainsi obtenus, employes notamment comme agents antibacteriens
SE8302394D0 (sv) Nya modifierade leror, framstellning derav och terapeutiska kompositioner innehallande dessa
RU92003985A (ru) Способ получения биоларвицидных препаратов

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee